There are currently more than 140 monoclonal antibodies (mAbs) approved by the FDA as biotherapeutic agents, representing the most rapidly growing class of new drugs. Therefore, rapid, accurate and cost-effective quantitation of mAbs is essential for bioprocessing.
Download this app note to discover a technique that:
- Accurately quantitates 5%, 10% and 20% mAb breakthrough values
- Performs at its best at low concentrations with an almost 30-fold lower LoQ
- Costs 20% lower in comparison to equivalent techniques